Sector ratings Grifols, S.A.

Equities

Market Closed - BME Other stock markets 16:35:27 19/09/2024 BST			After market 20:04:14
10.08 ^EUR	+0.15%		10.14	+0.63%

09-16	European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading	MT
09-13	Sector Update: Health Care Stocks Rise Friday Afternoon	MT

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Composite Valuation	ESG Refinitiv	Capi. ($)
GRIFOLS, S.A.		A-	7.02B
CSL LIMITED		A-	96.78B
SAMSUNG BIOLOGICS CO.,LTD.		A-	53.27B
UCB		A	33.6B
BIOGEN INC.		B-	28.87B
BIOMARIN PHARMACEUTICAL INC.		C	13.43B
ALTEOGEN INC.		D	12.83B
INCYTE CORPORATION		B-	12.79B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.		D+	12.26B
SWEDISH ORPHAN BIOVITRUM AB		B+	11.08B
INNOVENT BIOLOGICS, INC.		B-	9.17B
INTRA-CELLULAR THERAPIES, INC.	-	D+	7.94B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.		B	6.98B
SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.		C-	6.07B
BEIJING TIANTAN BIOLOGICAL PRODUCTS CO., LTD.		C	5.84B
BRIDGEBIO PHARMA, INC.	-	C-	5.03B
AVIDITY BIOSCIENCES, INC.	-	D	4.94B
AXSOME THERAPEUTICS, INC.	-	D	4.37B
ADMA BIOLOGICS, INC.	-	D+	4.36B
APELLIS PHARMACEUTICALS, INC.	-	C-	4.33B
Average		C+	17.05B
Weighted average by Cap.		C+